Translator Disclaimer
1 January 1989 Antagonism of Xylazine Hydrochloride Sedation in Raptors by Yohimbine Hydrochloride
Author Affiliations +
Abstract

The mean time to initial reversal response (MTIRR) and the mean time to perching (MTP) were measured in 34 raptors sedated with xylazine hydrochloride with dosages ranging from 1.0 to 20 mg/kg intravenously (i.v.) and 2.5 to 20.0 mg/kg intramuscularly (i.m). Yohimbine hydrochloride, given i.v. (0.2 mg/kg), 30 min after the injection of the xylazine, shortened the MTIRR and MTP compared to the controls. No adverse effects were noted due to the use of yohimbine. Yohimbine appeared to be a safe and effective antagonist for xylazine sedation in raptors.

Freed and Baker: Antagonism of Xylazine Hydrochloride Sedation in Raptors by Yohimbine Hydrochloride
Deborah Freed and Barbara Baker "Antagonism of Xylazine Hydrochloride Sedation in Raptors by Yohimbine Hydrochloride," Journal of Wildlife Diseases 25(1), (1 January 1989). https://doi.org/10.7589/0090-3558-25.1.136
Received: 13 August 1988; Published: 1 January 1989
JOURNAL ARTICLE
3 PAGES


SHARE
ARTICLE IMPACT
Back to Top